As of 2025-09-18, the EV/EBITDA ratio of Intra-Cellular Therapies Inc (ITCI) is -118.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ITCI's latest enterprise value is 13,739.84 mil USD. ITCI's TTM EBITDA according to its financial statements is -116.21 mil USD. Dividing these 2 quantities gives us the above ITCI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.6x - 15.2x | 11.6x |
| Forward P/E multiples | 12.1x - 16.0x | 14.6x |
| Fair Price | (10.28) - (13.75) | (11.41) |
| Upside | -107.8% - -110.4% | -108.7% |
| Date | EV/EBITDA |